Amsterdam UMC - VU Medisch Centrum

Amsterdam, North Holland 1081HV

1 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Disease Crohn, HER2-Positive Primary Breast Cancer, Moderately to Severely Active Crohn's Disease, Residual Invasive Breast Cancer

Studies at this site

• VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease — Recruiting now
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling